Nitric oxide and cyclic GMP are involved in angiotensin II AT2 receptor effects on neurite outgrowth in NG108-15 cells

Neuroendocrinology

Volumn 75, Issue 1, 2002, Pages 70-81

  Gendron, Louis ^a   Côté, Frédéric ^a   Payet, Marcel D ^a   Gallo Payet, Nicole ^a  

^a UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Angiotensin receptors; Angiotensins; Cyclic GMP; Differentiation; NG108 15 cells; Nitric oxyde

Indexed keywords

6 ANILINO 5,8 QUINOLINEQUINONE; ANGIOTENSIN 2 RECEPTOR; ANTIBODY; CYCLIC GMP; GUANYLATE CYCLASE; GUANYLATE CYCLASE INHIBITOR; KT 5823; METHYLENE BLUE; MITOGEN ACTIVATED PROTEIN KINASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHOSPHOTYROSINE ANTIBODY; PROTEIN P44; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; IMMUNOPRECIPITATION; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALKALOIDS; AMINOQUINOLINES; ANIMALS; CARBAZOLES; CELL DIFFERENTIATION; CYCLIC GMP; ENZYME INHIBITORS; GUANYLATE CYCLASE; INDOLES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEURITES; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PHOSPHORYLATION; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0036159731     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000048222     Document Type: Article

References (70)

1. Angiotensin II receptors in the human brain
2. 2) receptor mRNAs in the adult rat brain: A functional neuroanatomical review
3. The angiotensin type 2 receptor: Variations on a enigmatic theme
4. 2 receptors in cell growth
5. 2 receptor
6. Angiotensin II and nitric oxide: A question of balance
7. Angiotensin receptors: Molecular biology and signaling
8. Angiotensin II stimulates protein tyrosine phosphatase activity through a G-protein independent mechanism
9. 2 receptors are functionally coupled to protein tyrosine dephosphorylation in N1E-115 neuroblastoma cells
10. Angiotensin II type 2 receptor mediates programmed cell death
11. 2) receptor in R3T3 cells
12. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase
13. 2
14. 2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells
15. + currents involves an inhibitory GTP binding protein
16. Angiotensin II decreases cGMP levels in neuronal cultures from rat brain
17. 2 receptor mediated inhibition of particulate guanylate cyclase: A link with protein tyrosine phosphatase stimulation?
18. 2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase
19. 1 receptor-mediated prostaglandin E2 production in conscious rats
20. Losartan reduces phenylephrine constrictor response in aortic rings from spontaneously hypertensive rats. Role of nitric oxide and angiotensin II type 2 receptors
21. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism
22. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats
23. 2) angiotensin receptor
24. 2) receptor-mediated inhibition of NMDA receptor signaling in neuronal cells
25. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors
26. 2 angiotensin receptor gene expression in human heart failure
27. ras and activate MAPK to induce morphological neuronal differentiation in NG108-15 cells
28. 2 receptor stimulates ERK1 and ERK2 in quiescent but inhibits ERK in NGF-stimulated PC12W cells
29. i activation
30. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
31. Role of nitric oxide in the neural control of cardiovascular function
32. Nitric oxide synthase: Role as a transmitter/mediator in the brain and endocrine system
33. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways
34. Nitric oxide: Physiology, pathophysiology, and pharmacology
35. NO at work
36. Cyclic GMP-dependent protein kinase and cellular signaling in the nervous system
37. ras interaction
38. 1 receptors
39. 2 receptor of angiotensin II induces neurite outgrowth and cell migration in microexplant cultures of the cerebellum
40. Nitric oxide, a new second messenger involved in the action of angiotensin II on neuronal differentiation of NG108-15 cells
41. Acquisition of neuronal proteins during differentiation of NG108-15 cells
42. Nitric oxide triggers a switch to growth arrest during differentiation of neural cells
43. Growth factor induction of nitric oxide synthase in rat pheochromocytoma cells
44. A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21 WAF1 regulates neuronal differentiation of PC12 cells
45. Both neuronal NO synthase and nitric oxide are required for PC12 cell differentiation: A cGMP independent pathway
46. Culture and characteristics of hormone-responsive neuroblastoma x glioma hybrid cells
47. The activation of neuronal NO synthase is mediated by G-protein βγ subunit and the tyrosine phosphatase SHP-2
48. Gases as biological messengers: Nitric oxide and carbon monoxide in the brain
49. Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism
50. Endothelial nitric oxide synthase is regulated by tyrosine phosphorylation and interacts with caveolin-1
51. Rapid inactivation of NOS-I by lipopolysaccharide plus interferon-γ-induced tyrosine phosphorylation
52. Protein kinase G mediates vascular endothelial growth factor-induced Raf-1 activation and proliferation in human endothelial cells
53. Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5
54. Activation of mitogen-activated protein kinase pathway by cyclic GMP and cyclic GMP-dependent protein kinase in contractile vascular smooth muscle cells
55. Distinct mode of microtubule-associated proteins expression in the neuroblastoma, glioma cell line 108CC15/NG108-15
56. Implication of nitric oxide in NGF-induced cell differentiation: Differences between neuronal and beta cells
57. Regulation of neuronal growth cone filopodia by nitric oxide depends on soluble guanylyl cyclase
58. Nitric oxide donors enhance neurotrophin-induced neurite outgrowth through a cGMP-dependent mechanism
59. Activation of MAP kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells
60. Inhibition of MAP kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
61. Molecular cloning of a novel angiotensin II receptor isoform involved in phosphotyrosine phosphatase inhibition
62. iα3 in the rat fetus
63. Analysis of functional domains of angiotensin II type 2 receptor involved in apoptosis
64. Rising behind NO: cGMP-dependent protein kinases
65. Calmodulin-dependent activation of p38 and p42/44 mitogen-activated protein kinases contributes to c-fos expression by calcium in PC12 cells: Modulation by nitric oxide
66. Differential activation of mitogen-activated protein kinases by nitric oxide-related species
67. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor
68. Dynamic instability of individual microtubules analyzed by video light microscopy: Rate constants and transition frequencies
69. Role of microtubule-associated proteins in the control of microtubule assembly
70. Neurotrophins and the dynamic regulation of the neuronal cytoskeleton